1. Phthalazine derivatives containing imidazole rings behave as Fe-SOD inhibitors and show remarkable anti-T. cruzi activity in immunodeficient-mouse mode of infection.
- Author
-
Sánchez-Moreno M, Gómez-Contreras F, Navarro P, Marín C, Olmo F, Yunta MJ, Sanz AM, Rosales MJ, Cano C, and Campayo L
- Subjects
- Animals, Cell Death drug effects, Chagas Disease parasitology, Chlorocebus aethiops, Enzyme-Linked Immunosorbent Assay, Female, Imidazoles chemical synthesis, Imidazoles pharmacology, Mice, Mice, Inbred BALB C, Mice, Nude, Models, Molecular, Molecular Structure, Parasitemia etiology, Phthalazines chemical synthesis, Structure-Activity Relationship, Superoxide Dismutase metabolism, Trypanocidal Agents chemical synthesis, Vero Cells, Chagas Disease drug therapy, Imidazoles chemistry, Parasitemia prevention & control, Phthalazines chemistry, Phthalazines pharmacology, Trypanocidal Agents pharmacology, Trypanosoma cruzi drug effects
- Abstract
A series of new phthalazine derivatives 1-4 containing imidazole rings were prepared. The monoalkylamino substituted derivatives 2 and 4 were more active in vitro against T. cruzi and less toxic against Vero cells than both their disubstituted analogues and the reference drug benznidazole. Compounds 2 and 4 highly inhibited the antioxidant parasite enzyme Fe-SOD, and molecular modeling suggested that they interact with the H-bonding system of the iron atom moiety. In vivo tests on the acute phase of Chagas disease gave parasitemia inhibition values twice those of benznidazole, and a remarkable decrease in the reactivation of parasitemia was found in the chronic phase for immunodeficient mice. Glucose metabolism studies showed that compounds 1-4 did not affect the succinate pathway but originated important changes in the excretion of pyruvate metabolites. The morphological alterations found in epimastigotes treated with 1-4 confirmed extensive cytoplasm damage and a high mortality rate of parasites.
- Published
- 2012
- Full Text
- View/download PDF